Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) increases lung inflammation and activates pulmonary microvascular endothelial cells via an IL-4-dependent mechanism

Journal of Immunology

Volumn 185, Issue 9, 2010, Pages 5539-5548

  Yamaji Kegan, Kazuyo ^a   Su, Qingning ^a,b   Angelini, Daniel J ^a   Myers, Allen C ^a   Cheadle, Chris ^a   Johns, Roger A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Shenzhen University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COLLAGEN; HYPOXIA INDUCED MITOGENIC FACTOR; HYPOXIA INDUCIBLE FACTOR; INFLAMMATORY ZONE 1 PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; RESISTIN LIKE MOLECULE ALPHA; STAT6 PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; RETNLA PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HYPERTROPHY; HYPOXIA; KNOCKOUT MOUSE; LUNG ALVEOLUS CELL; LUNG FIBROSIS; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; TH2 CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL MOTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG; METABOLISM; MOUSE MUTANT; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPERTENSION, PULMONARY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-4; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; PNEUMONIA; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 78149473681     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904021     Document Type: Article

References (69)

1. Rubin, L. J. 1997. Primary pulmonary hypertension. N. Engl. J. Med. 336:111-117.
2. Teng, X., D. Li, H. C. Champion, and R. A. Johns. 2003. FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ. Res. 92:1065-1067.
3. Holcomb, I. N., R. C. Kabakoff, B. Chan, T. W. Baker, A. Gurney, W. Henzel, C. Nelson, H. B. Lowman, B. D. Wright, N. J. Skelton, et al. 2000. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19:4046-4055.
4. Liu, T., H. Jin, M. Ullenbruch, B. Hu, N. Hashimoto, B. Moore, A. McKenzie, N. W. Lukacs, and S. H. Phan. 2004. Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6. J. Immunol. 173:3425-3431.
5. Yamaji-Kegan, K., Q. Su, D. J. Angelini, H. C. Champion, and R. A. Johns. 2006. Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1159-L1168.
6. Su, Q., Y. Zhou, and R. A. Johns. 2007. Bruton's tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis. FASEB J. 21:1376-1382.
7. Angelini, D. J., Q. Su, K. Yamaji-Kegan, C. Fan, J. T. Skinner, H. C. Champion, M. T. Crow, and R. A. Johns. 2009. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) induces the vascular and hemodynamic changes of pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L582-L593.
8. Angelini, D. J., Q. Su, I. A. Kolosova, C. Fan, J. T. Skinner, K. Yamaji-Kegan, M. Collector, S. J. Sharkis, and R. A. Johns. 2010. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELM alpha) recruits bone marrow-derived cells to the murine pulmonary vasculature. PLoS ONE 5: e11251.
9. Liu, T., S. M. Dhanasekaran, H. Jin, B. Hu, S. A. Tomlins, A. M. Chinnaiyan, and S. H. Phan. 2004. FIZZ1 stimulation of myofibroblast differentiation. Am. J. Pathol. 164:1315-1326.
10. Raes, G., P. De Baetselier, W. Noël, A. Beschin, F. Brombacher, and G. Hassanzadeh Gh. 2002. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71:597-602.
11. Stütz, A. M., L. A. Pickart, A. Trifilieff, T. Baumruker, E. Prieschl-Strassmayr, and M. Woisetschläger. 2003. The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism. J. Immunol. 170:1789-1796.
12. Nair, M. G., Y. Du, J. G. Perrigoue, C. Zaph, J. J. Taylor, M. Goldschmidt, G. P. Swain, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, et al. 2009. Alternatively activated macrophage-derived RELM-alpha is a negative regulator of type 2 inflammation in the lung. J. Exp. Med. 206:937-952.
13. Snapper, C. M., and W. E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947.
14. Rankin, J. A., D. E. Picarella, G. P. Geba, U. A. Temann, B. Prasad, B. DiCosmo, A. Tarallo, B. Stripp, J. Whitsett, and R. A. Flavell. 1996. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA 93:7821-7825.
15. Voehringer, D., K. Shinkai, and R. M. Locksley. 2004. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 20:267-277.
16. Richter, A., S. M. Puddicombe, J. L. Lordan, F. Bucchieri, S. J. Wilson, R. Djukanovic, G. Dent, S. T. Holgate, and D. E. Davies. 2001. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am. J. Respir. Cell Mol. Biol. 25:385-391.
17. Jain-Vora, S., S. E. Wert, U. A. Temann, J. A. Rankin, and J. A. Whitsett. 1997. Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung. Am. J. Respir. Cell Mol. Biol. 17:541-551.
18. Leigh, R., R. Ellis, J. N. Wattie, J. A. Hirota, K. I. Matthaei, P. S. Foster, P. M. O'Byrne, and M. D. Inman. 2004. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am. J. Respir. Crit. Care Med. 169:860-867.
19. Saito, A., H. Okazaki, I. Sugawara, K. Yamamoto, and H. Takizawa. 2003. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int. Arch. Allergy Immunol. 132:168-176.
20. Shimizu, K., M. Shichiri, P. Libby, R. T. Lee, and R. N. Mitchell. 2004. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J. Clin. Invest. 114:300-308.
21. Leonardi, A., R. Cortivo, I. Fregona, M. Plebani, A. G. Secchi, and G. Abatangelo. 2003. Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts. Invest. Ophthalmol. Vis. Sci. 44:183-189.
22. Nelms, K., A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701-738.
23. Hashimoto, S., Y. Gon, I. Takeshita, S. Maruoka, and T. Horie. 2001. IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun. NH2-terminal kinase-dependent pathway. J. Allergy Clin. Immunol. 107:1001-1008.
24. Hashimoto-Uoshima, M., K. Noguchi, M. Suzuki, A. Murata, M. Yanagishita, and I. Ishikawa. 2002. Effects of interleukin-4 on proteoglycan accumulation in human gingival fibroblasts. J. Periodontal Res. 37:42-49.
25. Galea, P., A. Chartier, and Y. Lebranchu. 1991. Increased lymphocyte adhesion to allogeneic endothelial cells by interleukin-4 (IL-4). Transplant. Proc. 23:243-244.
26. Lee, Y. W., H. Kühn, B. Hennig, A. S. Neish, and M. Toborek. 2001. IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J. Mol. Cell. Cardiol. 33:83-94.
27. Thornhill, M. H., U. Kyan-Aung, and D. O. Haskard. 1990. IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J. Immunol. 144:3060-3065.
28. Rollins, B. J., and J. S. Pober. 1991. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am. J. Pathol. 138:1315-1319.
29. Lee, Y. W., B. Hennig, and M. Toborek. 2003. Redox-regulated mechanisms of IL-4-induced MCP-1 expression in human vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 284: H185-H192.
30. Khew-Goodall, Y., C. Wadham, B. N. Stein, J. R. Gamble, and M. A. Vadas. 1999. Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19:1421-1429.
31. Daley, E., C. Emson, C. Guignabert, R. de Waal Malefyt, J. Louten, V. P. Kurup, C. Hogaboam, L. Taraseviciene-Stewart, N. F. Voelkel, M. Rabinovitch, et al. 2008. Pulmonary arterial remodeling induced by a Th2 immune response. J. Exp. Med. 205:361-372.
32. Yamaji-Kegan, K., Q. Su, D. J. Angelini, and R. A. Johns. 2009. IL-4 is proangiogenic in the lung under hypoxic conditions. J. Immunol. 182:5469-5476.
33. Ma, B., M. R. Blackburn, C. G. Lee, R. J. Homer, W. Liu, R. A. Flavell, L. Boyden, R. P. Lifton, C. X. Sun, H. W. Young, and J. A. Elias. 2006. Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J. Clin. Invest. 116:1274-1283.
34. Girgis, R. E., S. Mozammel, H. C. Champion, D. Li, X. Peng, L. Shimoda, R. M. Tuder, R. A. Johns, and P. M. Hassoun. 2007. Regression of chronic hypoxic pulmonary hypertension by simvastatin. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1105-L1110.
35. Reinhardt, A. K., S. E. Bottoms, G. J. Laurent, and R. J. McAnulty. 2005. Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling. Respir. Res. 6:30.
36. Siminski, J. T., T. J. Kavanagh, E. Chi, and G. Raghu. 1992. Long-term maintenance of mature pulmonary parenchyma cultured in serum-free conditions. Am. J. Physiol. 262: L105-L110.
37. Moldobaeva, A., and E. M. Wagner. 2005. Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L1117-L1123.
38. Lee, C. G., H. J. Yoon, Z. Zhu, H. Link, Z. Wang, J. M. Gwaltney, M. Landry, and J. A. Elias. 2000. Respiratory syncytial virus stimulation of vascular endothelial cell growth Factor/Vascular permeability factor. Am. J. Respir. Cell Mol. Biol. 23:662-669.
39. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (2Delta Delta C (T)) Method. Methods 25:402-408.
40. Stevens, T., S. Phan, M. G. Frid, D. Alvarez, E. Herzog, and K. R. Stenmark. 2008. Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts. Proc. Am. Thorac. Soc. 5:783-791.
41. Stenmark, K. R., K. A. Fagan, and M. G. Frid. 2006. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ. Res. 99:675-691.
42. Jeffery, T. K., and J. C. Wanstall. 2001. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol. Ther. 92:1-20.
43. Doucet, C., D. Brouty-Boyé, C. Pottin-Clémenceau, G. W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 101:2129-2139.
44. Huaux, F., T. Liu, B. McGarry, M. Ullenbruch, and S. H. Phan. 2003. Dual roles of IL-4 in lung injury and fibrosis. J. Immunol. 170:2083-2092.
45. Lin, J. X., T. S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, et al. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-339.
46. Fallon, P. G., E. J. Richardson, G. J. McKenzie, and A. N. McKenzie. 2000. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 164:2585-2591.
47. Johns, R. A. 2010. Th2 inflammation, hypoxia-induced mitogenic factor/FIZZ1, and pulmonary hypertension and vascular remodeling in schistosomiasis. Am. J. Respir. Crit. Care Med. 181:203-205.
48. Bhattacharya, J. 2008. Lung neovascularization: a tale of two circulations. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L417-L418.
49. Hyvelin, J. M., K. Howell, A. Nichol, C. M. Costello, R. J. Preston, and P. McLoughlin. 2005. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ. Res. 97:185-191.
50. Sawano, A., S. Iwai, Y. Sakurai, M. Ito, K. Shitara, T. Nakahata, and M. Shibuya. 2001. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97:785-791.
51. Davie, N. J., J. T. Crossno, Jr., M. G. Frid, S. E. Hofmeister, J. T. Reeves, D. M. Hyde, T. C. Carpenter, J. A. Brunetti, I. K. McNiece, and K. R. Stenmark. 2004. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L668-L678.
52. Becker, P. M., A. Alcasabas, A. Y. Yu, G. L. Semenza, and T. E. Bunton. 2000. Oxygen-independent upregulation of vascular endothelial growth factor and vascular barrier dysfunction during ventilated pulmonary ischemia in isolated ferret lungs. Am. J. Respir. Cell Mol. Biol. 22:272-279.
53. Christou, H., A. Yoshida, V. Arthur, T. Morita, and S. Kourembanas. 1998. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 18:768-776.
54. Thickett, D. R., L. Armstrong, and A. B. Millar. 2002. A role for vascular endothelial growth factor in acute and resolving lung injury. Am. J. Respir. Crit. Care Med. 166:1332-1337.
55. Murdoch, C., A. Giannoudis, and C. E. Lewis. 2004. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104:2224-2234.
56. Fukushi, J., T. Morisaki, T. Shono, A. Nishie, H. Torisu, M. Ono, and M. Kuwano. 1998. Novel biological functions of interleukin-4: formation of tube-like structures by vascular endothelial cells in vitro and angiogenesis in vivo. Biochem. Biophys. Res. Commun. 250:444-448.
57. Gu, L., S. Tseng, R. M. Horner, C. Tam, M. Loda, and B. J. Rollins. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407-411.
58. Stenmark, K. R., N. J. Davie, J. T. Reeves, and M. G. Frid. 2005. Hypoxia, leukocytes, and the pulmonary circulation. J. Appl. Physiol. 98:715-721.
59. Hashimoto, N., H. Jin, T. Liu, S. W. Chensue, and S. H. Phan. 2004. Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 113:243-252.
60. Ceradini, D. J., A. R. Kulkarni, M. J. Callaghan, O. M. Tepper, N. Bastidas, M. E. Kleinman, J. M. Capla, R. D. Galiano, J. P. Levine, and G. C. Gurtner. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10:858-864.
61. Young, K. C., E. Torres, K. E. Hatzistergos, D. Hehre, C. Suguihara, and J. M. Hare. 2009. Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ. Res. 104:1293-1301.
62. Semenza, G. L. 2009. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24:97-106.
63. Peng, Y. J., G. Yuan, D. Ramakrishnan, S. D. Sharma, M. Bosch-Marce, G. K. Kumar, G. L. Semenza, and N. R. Prabhakar. 2006. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J. Physiol. 577:705-716.
64. Frid, M. G., J. A. Brunetti, D. L. Burke, T. C. Carpenter, N. J. Davie, J. T. Reeves, M. T. Roedersheimer, N. van Rooijen, and K. R. Stenmark. 2006. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am. J. Pathol. 168:659-669.
65. Spees, J. L., M. J. Whitney, D. E. Sullivan, J. A. Lasky, M. Laboy, J. Ylostalo, and D. J. Prockop. 2008. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J. 22:1226-1236.
66. Johns, R. A., and K. Yamaji-Kegan. 2009. Unveiling cell phenotypes in lung vascular remodeling. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L1056-L1058.
67. Burke, D. L., M. G. Frid, C. L. Kunrath, V. Karoor, A. Anwar, B. D. Wagner, D. Strassheim, and K. R. Stenmark. 2009. Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L238-L250.
68. Milne, E. N., and E. A. Zerhouni. 1987. Blood supply of pulmonary metastases. J. Thorac. Imaging 2:15-23.
69. Stenmark, K. R., B. Meyrick, N. Galie, W. J. Mooi, and I. F. McMurtry. 2009. Animal models of pulmonary arterial hypertension: the hope for etiologic discovery and pharmacologic cure. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L1013-L1032.